Industry Research Reports

Home > Reports > Chemical & Material > Global Lenalidomide API Market Research Report 2026

Global Lenalidomide API Market Research Report 2026

Industry: Chemical & Material

Published Date: 2026-04-21

Pages: 134 Pages

Report ld: 6551281

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Lenalidomide API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Lenalidomide API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.

The North American market for Lenalidomide API is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Lenalidomide API is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Lenalidomide API include Dr. Reddy’s Laboratories Ltd., Johnson Matthey PLC, Changzhou Pharmaceutical Factory, Shilpa Medicare Limited, Biocon Limited, Sun Pharmaceutical Industries Ltd., Shenzhen Haorui, Mac-Chem Products (India) Pvt.Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Lenalidomide API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lenalidomide API. The Lenalidomide API market size, estimates, and forecasts are provided in terms of output/shipments (Ton) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Lenalidomide API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Lenalidomide API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Dr. Reddy’s Laboratories Ltd.
Johnson Matthey PLC
Changzhou Pharmaceutical Factory
Shilpa Medicare Limited
Biocon Limited
Sun Pharmaceutical Industries Ltd.
Shenzhen Haorui
Mac-Chem Products (India) Pvt.Ltd

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Purity≥98%
Purity<98%

Segment by Application

Lenalidomide capsules
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Provides a detailed analysis of the competitive landscape for Lenalidomide API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.

Chapter 3: Examines Lenalidomide API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.

Chapter 4: Analyzes Lenalidomide API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.

Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.

Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.

Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.

Chapter 8: Reviews the industry value chain, including upstream and downstream segments.

Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.

Chapter 10: Summarizes the key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Lenalidomide API Market Overview

1.1 Product Definition

1.2 Lenalidomide API by Type

1.2.1 Global Lenalidomide API Market Value Growth Rate Analysis by Type: 2025 vs 2032

1.2.2 Purity≥98%

1.2.3 Purity<98%

1.3 Lenalidomide API by Application

1.3.1 Global Lenalidomide API Market Value Growth Rate Analysis by Application: 2025 vs 2032

1.3.2 Lenalidomide capsules

1.3.3 Others

1.4 Global Market Growth Prospects

1.4.1 Global Lenalidomide API Production Value Estimates and Forecasts (2021–2032)

1.4.2 Global Lenalidomide API Production Capacity Estimates and Forecasts (2021–2032)

1.4.3 Global Lenalidomide API Production Estimates and Forecasts (2021–2032)

1.4.4 Global Lenalidomide API Market Average Price Estimates and Forecasts (2021–2032)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Lenalidomide API Production Market Share by Manufacturers (2021–2026)

2.2 Global Lenalidomide API Production Value Market Share by Manufacturers (2021–2026)

2.3 Global Key Players of Lenalidomide API, Industry Ranking, 2024 vs 2025

2.4 Global Lenalidomide API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.5 Global Lenalidomide API Average Price by Manufacturers (2021–2026)

2.6 Global Key Manufacturers of Lenalidomide API, Manufacturing Footprints and Headquarters

2.7 Global Key Manufacturers of Lenalidomide API, Product Offerings and Applications

2.8 Global Key Manufacturers of Lenalidomide API, Date of Entry into the Industry

2.9 Lenalidomide API Market Competitive Situation and Trends

2.9.1 Lenalidomide API Market Concentration Rate

2.9.2 Top 5 and Top 10 Global Lenalidomide API Players Market Share by Revenue

2.10 Mergers & Acquisitions and Expansion

3 Lenalidomide API Production by Region

3.1 Global Lenalidomide API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.2 Global Lenalidomide API Production Value by Region (2021–2032)

3.2.1 Global Lenalidomide API Production Value by Region (2021–2026)

3.2.2 Global Forecasted Production Value of Lenalidomide API by Region (2027–2032)

3.3 Global Lenalidomide API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.4 Global Lenalidomide API Production Volume by Region (2021–2032)

3.4.1 Global Lenalidomide API Production by Region (2021–2026)

3.4.2 Global Forecasted Production of Lenalidomide API by Region (2027–2032)

3.5 Global Lenalidomide API Market Price Analysis by Region (2021–2032)

3.6 Global Lenalidomide API Production, Value, and Year-over-Year Growth

3.6.1 India Lenalidomide API Production Value Estimates and Forecasts (2021–2032)

3.6.2 Europe Lenalidomide API Production Value Estimates and Forecasts (2021–2032)

3.6.3 China Lenalidomide API Production Value Estimates and Forecasts (2021–2032)

4 Lenalidomide API Consumption by Region

4.1 Global Lenalidomide API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

4.2 Global Lenalidomide API Consumption by Region (2021–2032)

4.2.1 Global Lenalidomide API Consumption by Region (2021–2026)

4.2.2 Global Lenalidomide API Forecasted Consumption by Region (2027–2032)

4.3 North America

4.3.1 North America Lenalidomide API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.3.2 North America Lenalidomide API Consumption by Country (2021–2032)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Lenalidomide API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.4.2 Europe Lenalidomide API Consumption by Country (2021–2032)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Lenalidomide API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032

4.5.2 Asia Pacific Lenalidomide API Consumption by Region (2021–2032)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Lenalidomide API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.6.2 Latin America, Middle East & Africa Lenalidomide API Consumption by Country (2021–2032)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Lenalidomide API Production by Type (2021–2032)

5.1.1 Global Lenalidomide API Production by Type (2021–2026)

5.1.2 Global Lenalidomide API Production by Type (2027–2032)

5.1.3 Global Lenalidomide API Production Market Share by Type (2021–2032)

5.2 Global Lenalidomide API Production Value by Type (2021–2032)

5.2.1 Global Lenalidomide API Production Value by Type (2021–2026)

5.2.2 Global Lenalidomide API Production Value by Type (2027–2032)

5.2.3 Global Lenalidomide API Production Value Market Share by Type (2021–2032)

5.3 Global Lenalidomide API Price by Type (2021–2032)

6 Segment by Application

6.1 Global Lenalidomide API Production by Application (2021–2032)

6.1.1 Global Lenalidomide API Production by Application (2021–2026)

6.1.2 Global Lenalidomide API Production by Application (2027–2032)

6.1.3 Global Lenalidomide API Production Market Share by Application (2021–2032)

6.2 Global Lenalidomide API Production Value by Application (2021–2032)

6.2.1 Global Lenalidomide API Production Value by Application (2021–2026)

6.2.2 Global Lenalidomide API Production Value by Application (2027–2032)

6.2.3 Global Lenalidomide API Production Value Market Share by Application (2021–2032)

6.3 Global Lenalidomide API Price by Application (2021–2032)

7 Key Companies Profiled

7.1 Dr. Reddy’s Laboratories Ltd.

7.1.1 Dr. Reddy’s Laboratories Ltd. Lenalidomide API Company Information

7.1.2 Dr. Reddy’s Laboratories Ltd. Lenalidomide API Product Portfolio

7.1.3 Dr. Reddy’s Laboratories Ltd. Lenalidomide API Production, Value, Price, and Gross Margin (2021–2026)

7.1.4 Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served

7.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates

7.2 Johnson Matthey PLC

7.2.1 Johnson Matthey PLC Lenalidomide API Company Information

7.2.2 Johnson Matthey PLC Lenalidomide API Product Portfolio

7.2.3 Johnson Matthey PLC Lenalidomide API Production, Value, Price, and Gross Margin (2021–2026)

7.2.4 Johnson Matthey PLC Main Business and Markets Served

7.2.5 Johnson Matthey PLC Recent Developments/Updates

7.3 Changzhou Pharmaceutical Factory

7.3.1 Changzhou Pharmaceutical Factory Lenalidomide API Company Information

7.3.2 Changzhou Pharmaceutical Factory Lenalidomide API Product Portfolio

7.3.3 Changzhou Pharmaceutical Factory Lenalidomide API Production, Value, Price, and Gross Margin (2021–2026)

7.3.4 Changzhou Pharmaceutical Factory Main Business and Markets Served

7.3.5 Changzhou Pharmaceutical Factory Recent Developments/Updates

7.4 Shilpa Medicare Limited

7.4.1 Shilpa Medicare Limited Lenalidomide API Company Information

7.4.2 Shilpa Medicare Limited Lenalidomide API Product Portfolio

7.4.3 Shilpa Medicare Limited Lenalidomide API Production, Value, Price, and Gross Margin (2021–2026)

7.4.4 Shilpa Medicare Limited Main Business and Markets Served

7.4.5 Shilpa Medicare Limited Recent Developments/Updates

7.5 Biocon Limited

7.5.1 Biocon Limited Lenalidomide API Company Information

7.5.2 Biocon Limited Lenalidomide API Product Portfolio

7.5.3 Biocon Limited Lenalidomide API Production, Value, Price, and Gross Margin (2021–2026)

7.5.4 Biocon Limited Main Business and Markets Served

7.5.5 Biocon Limited Recent Developments/Updates

7.6 Sun Pharmaceutical Industries Ltd.

7.6.1 Sun Pharmaceutical Industries Ltd. Lenalidomide API Company Information

7.6.2 Sun Pharmaceutical Industries Ltd. Lenalidomide API Product Portfolio

7.6.3 Sun Pharmaceutical Industries Ltd. Lenalidomide API Production, Value, Price, and Gross Margin (2021–2026)

7.6.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served

7.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates

7.7 Shenzhen Haorui

7.7.1 Shenzhen Haorui Lenalidomide API Company Information

7.7.2 Shenzhen Haorui Lenalidomide API Product Portfolio

7.7.3 Shenzhen Haorui Lenalidomide API Production, Value, Price, and Gross Margin (2021–2026)

7.7.4 Shenzhen Haorui Main Business and Markets Served

7.7.5 Shenzhen Haorui Recent Developments/Updates

7.8 Mac-Chem Products (India) Pvt.Ltd

7.8.1 Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Company Information

7.8.2 Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Product Portfolio

7.8.3 Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Production, Value, Price, and Gross Margin (2021–2026)

7.8.4 Mac-Chem Products (India) Pvt.Ltd Main Business and Markets Served

7.8.5 Mac-Chem Products (India) Pvt.Ltd Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Lenalidomide API Industry Chain Analysis

8.2 Lenalidomide API Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Lenalidomide API Production Modes and Processes

8.4 Lenalidomide API Sales and Marketing

8.4.1 Lenalidomide API Sales Channels

8.4.2 Lenalidomide API Distributors

8.5 Lenalidomide API Customer Analysis

9 Lenalidomide API Market Dynamics

9.1 Lenalidomide API Industry Trends

9.2 Lenalidomide API Market Drivers

9.3 Lenalidomide API Market Challenges

9.4 Lenalidomide API Market Restraints

9.5 Impact of U.S. Tariffs

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Lenalidomide API Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Lenalidomide API Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Lenalidomide API Production Capacity (Ton) by Manufacturers in 2025

Table 4. Global Lenalidomide API Production by Manufacturers (Ton), 2021–2026

Table 5. Global Lenalidomide API Production Market Share by Manufacturers (2021–2026)

Table 6. Global Lenalidomide API Production Value by Manufacturers (US$ Million), 2021–2026

Table 7. Global Lenalidomide API Production Value Share by Manufacturers (2021–2026)

Table 8. Global Key Players of Lenalidomide API, Industry Ranking, 2024 vs 2025

Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Lenalidomide API Production Value, 2025

Table 10. Global Market Lenalidomide API Average Price by Manufacturers (US$/Ton), 2021–2026

Table 11. Global Key Manufacturers of Lenalidomide API, Manufacturing Footprints and Headquarters

Table 12. Global Key Manufacturers of Lenalidomide API, Product Offerings and Applications

Table 13. Global Key Manufacturers of Lenalidomide API, Date of Entry into the Industry

Table 14. Global Lenalidomide API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Lenalidomide API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Lenalidomide API Production Value (US$ Million) by Region (2021–2026)

Table 18. Global Lenalidomide API Production Value Market Share by Region (2021–2026)

Table 19. Global Lenalidomide API Production Value (US$ Million) Forecast by Region (2027–2032)

Table 20. Global Lenalidomide API Production Value Market Share Forecast by Region (2027–2032)

Table 21. Global Lenalidomide API Production Comparison by Region: 2021 vs 2025 vs 2032 (Ton)

Table 22. Global Lenalidomide API Production (Ton) by Region (2021–2026)

Table 23. Global Lenalidomide API Production Market Share by Region (2021–2026)

Table 24. Global Lenalidomide API Production (Ton) Forecast by Region (2027–2032)

Table 25. Global Lenalidomide API Production Market Share Forecast by Region (2027–2032)

Table 26. Global Lenalidomide API Market Average Price (US$/Ton) by Region (2021–2026)

Table 27. Global Lenalidomide API Market Average Price (US$/Ton) by Region (2027–2032)

Table 28. Global Lenalidomide API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Ton)

Table 29. Global Lenalidomide API Consumption by Region (Ton), 2021–2026

Table 30. Global Lenalidomide API Consumption Market Share by Region (2021–2026)

Table 31. Global Lenalidomide API Forecasted Consumption by Region (Ton), 2027–2032

Table 32. Global Lenalidomide API Forecasted Consumption Market Share by Region (2027–2032)

Table 33. North America Lenalidomide API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Ton)

Table 34. North America Lenalidomide API Consumption by Country (Ton), 2021–2026

Table 35. North America Lenalidomide API Consumption by Country (Ton), 2027–2032

Table 36. Europe Lenalidomide API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Ton)

Table 37. Europe Lenalidomide API Consumption by Country (Ton), 2021–2026

Table 38. Europe Lenalidomide API Consumption by Country (Ton), 2027–2032

Table 39. Asia Pacific Lenalidomide API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Ton)

Table 40. Asia Pacific Lenalidomide API Consumption by Region (Ton), 2021–2026

Table 41. Asia Pacific Lenalidomide API Consumption by Region (Ton), 2027–2032

Table 42. Latin America, Middle East & Africa Lenalidomide API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Ton)

Table 43. Latin America, Middle East & Africa Lenalidomide API Consumption by Country (Ton), 2021–2026

Table 44. Latin America, Middle East & Africa Lenalidomide API Consumption by Country (Ton), 2027–2032

Table 45. Global Lenalidomide API Production (Ton) by Type (2021–2026)

Table 46. Global Lenalidomide API Production (Ton) by Type (2027–2032)

Table 47. Global Lenalidomide API Production Market Share by Type (2021–2026)

Table 48. Global Lenalidomide API Production Market Share by Type (2027–2032)

Table 49. Global Lenalidomide API Production Value (US$ Million) by Type (2021–2026)

Table 50. Global Lenalidomide API Production Value (US$ Million) by Type (2027–2032)

Table 51. Global Lenalidomide API Production Value Market Share by Type (2021–2026)

Table 52. Global Lenalidomide API Production Value Market Share by Type (2027–2032)

Table 53. Global Lenalidomide API Price (US$/Ton) by Type (2021–2026)

Table 54. Global Lenalidomide API Price (US$/Ton) by Type (2027–2032)

Table 55. Global Lenalidomide API Production (Ton) by Application (2021–2026)

Table 56. Global Lenalidomide API Production (Ton) by Application (2027–2032)

Table 57. Global Lenalidomide API Production Market Share by Application (2021–2026)

Table 58. Global Lenalidomide API Production Market Share by Application (2027–2032)

Table 59. Global Lenalidomide API Production Value (US$ Million) by Application (2021–2026)

Table 60. Global Lenalidomide API Production Value (US$ Million) by Application (2027–2032)

Table 61. Global Lenalidomide API Production Value Market Share by Application (2021–2026)

Table 62. Global Lenalidomide API Production Value Market Share by Application (2027–2032)

Table 63. Global Lenalidomide API Price (US$/Ton) by Application (2021–2026)

Table 64. Global Lenalidomide API Price (US$/Ton) by Application (2027–2032)

Table 65. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Company Information

Table 66. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Specification and Application

Table 67. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 68. Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served

Table 69. Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates

Table 70. Johnson Matthey PLC Lenalidomide API Company Information

Table 71. Johnson Matthey PLC Lenalidomide API Specification and Application

Table 72. Johnson Matthey PLC Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 73. Johnson Matthey PLC Main Business and Markets Served

Table 74. Johnson Matthey PLC Recent Developments/Updates

Table 75. Changzhou Pharmaceutical Factory Lenalidomide API Company Information

Table 76. Changzhou Pharmaceutical Factory Lenalidomide API Specification and Application

Table 77. Changzhou Pharmaceutical Factory Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 78. Changzhou Pharmaceutical Factory Main Business and Markets Served

Table 79. Changzhou Pharmaceutical Factory Recent Developments/Updates

Table 80. Shilpa Medicare Limited Lenalidomide API Company Information

Table 81. Shilpa Medicare Limited Lenalidomide API Specification and Application

Table 82. Shilpa Medicare Limited Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 83. Shilpa Medicare Limited Main Business and Markets Served

Table 84. Shilpa Medicare Limited Recent Developments/Updates

Table 85. Biocon Limited Lenalidomide API Company Information

Table 86. Biocon Limited Lenalidomide API Specification and Application

Table 87. Biocon Limited Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 88. Biocon Limited Main Business and Markets Served

Table 89. Biocon Limited Recent Developments/Updates

Table 90. Sun Pharmaceutical Industries Ltd. Lenalidomide API Company Information

Table 91. Sun Pharmaceutical Industries Ltd. Lenalidomide API Specification and Application

Table 92. Sun Pharmaceutical Industries Ltd. Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 93. Sun Pharmaceutical Industries Ltd. Main Business and Markets Served

Table 94. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates

Table 95. Shenzhen Haorui Lenalidomide API Company Information

Table 96. Shenzhen Haorui Lenalidomide API Specification and Application

Table 97. Shenzhen Haorui Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 98. Shenzhen Haorui Main Business and Markets Served

Table 99. Shenzhen Haorui Recent Developments/Updates

Table 100. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Company Information

Table 101. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Specification and Application

Table 102. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 103. Mac-Chem Products (India) Pvt.Ltd Main Business and Markets Served

Table 104. Mac-Chem Products (India) Pvt.Ltd Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Lenalidomide API Distributors List

Table 108. Lenalidomide API Customers List

Table 109. Lenalidomide API Market Trends

Table 110. Lenalidomide API Market Drivers

Table 111. Lenalidomide API Market Challenges

Table 112. Lenalidomide API Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Lenalidomide API

Figure 2. Global Lenalidomide API Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Lenalidomide API Market Share by Type: 2025 vs 2032

Figure 4. Purity≥98% Product Picture

Figure 5. Purity<98% Product Picture

Figure 6. Global Lenalidomide API Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Lenalidomide API Market Share by Application: 2025 vs 2032

Figure 8. Lenalidomide capsules

Figure 9. Others

Figure 10. Global Lenalidomide API Production Value (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Lenalidomide API Production Value (US$ Million), 2021–2032

Figure 12. Global Lenalidomide API Production Capacity (Ton), 2021–2032

Figure 13. Global Lenalidomide API Production (Ton), 2021–2032

Figure 14. Global Lenalidomide API Average Price (US$/Ton), 2021–2032

Figure 15. Lenalidomide API Report Years Considered

Figure 16. Lenalidomide API Production Share by Manufacturers in 2025

Figure 17. Global Lenalidomide API Production Value Share by Manufacturers (2025)

Figure 18. Lenalidomide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 19. Top 5 and Top 10 Global Players: Market Share by Lenalidomide API Revenue in 2025

Figure 20. Global Lenalidomide API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 21. Global Lenalidomide API Production Value Market Share by Region: 2021 vs 2025 vs 2032

Figure 22. Global Lenalidomide API Production Comparison by Region: 2021 vs 2025 vs 2032 (Ton)

Figure 23. Global Lenalidomide API Production Market Share by Region: 2021 vs 2025 vs 2032

Figure 24. India Lenalidomide API Production Value (US$ Million) Growth Rate (2021–2032)

Figure 25. Europe Lenalidomide API Production Value (US$ Million) Growth Rate (2021–2032)

Figure 26. China Lenalidomide API Production Value (US$ Million) Growth Rate (2021–2032)

Figure 27. Global Lenalidomide API Consumption by Region: 2021 vs 2025 vs 2032 (Ton)

Figure 28. Global Lenalidomide API Consumption Market Share by Region: 2021 vs 2025 vs 2032

Figure 29. North America Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 30. North America Lenalidomide API Consumption Market Share by Country (2021–2032)

Figure 31. U.S. Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 32. Canada Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 33. Europe Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 34. Europe Lenalidomide API Consumption Market Share by Country (2021–2032)

Figure 35. Germany Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 36. France Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 37. U.K. Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 38. Italy Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 39. Russia Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 40. Asia Pacific Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 41. Asia Pacific Lenalidomide API Consumption Market Share by Region (2021–2032)

Figure 42. China Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 43. Japan Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 44. South Korea Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 45. China Taiwan Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 46. Southeast Asia Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 47. India Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 48. Latin America, Middle East & Africa Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 49. Latin America, Middle East & Africa Lenalidomide API Consumption Market Share by Country (2021–2032)

Figure 50. Mexico Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 51. Brazil Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 52. Turkey Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 53. GCC Countries Lenalidomide API Consumption and Growth Rate (Ton), 2021–2032

Figure 54. Global Production Market Share of Lenalidomide API by Type (2021–2032)

Figure 55. Global Production Value Market Share of Lenalidomide API by Type (2021–2032)

Figure 56. Global Lenalidomide API Price (US$/Ton) by Type (2021–2032)

Figure 57. Global Production Market Share of Lenalidomide API by Application (2021–2032)

Figure 58. Global Production Value Market Share of Lenalidomide API by Application (2021–2032)

Figure 59. Global Lenalidomide API Price (US$/Ton) by Application (2021–2032)

Figure 60. Lenalidomide API Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Lenalidomide API market? zhanKai

The top companies in the global Lenalidomide API market are Dr. Reddy’s Laboratories Ltd.、Johnson Matthey PLC、Changzhou Pharmaceutical Factory.

Related Reports

Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lenalidomide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 126
USD 3950.00
(Single User License)
Global Lenalidomide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lenalidomide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 139
USD 4900.00
(Single User License)
Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lenalidomide API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 99
USD 3950.00
(Single User License)
Global Lenalidomide API Market Research Report 2025
The global market for Lenalidomide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 95
USD 2900.00
(Single User License)
Global Lenalidomide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lenalidomide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 77
USD 4250.00
(Single User License)
Global Lenalidomide API Market Insights, Forecast to 2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published Date: 2024-04-15
Pages: 95
USD 4900.00
(Single User License)
Lenalidomide API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published Date: 2024-02-23
Pages: 97
USD 3950.00
(Single User License)
Global Lenalidomide API Market Research Report 2024
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published Date: 2024-01-10
Pages: 85
USD 2900.00
(Single User License)

Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lenalidomide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 126
USD 3950.00 (Single User License)
Global Lenalidomide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lenalidomide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 139
USD 4900.00 (Single User License)
Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lenalidomide API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 99
USD 3950.00 (Single User License)
Global Lenalidomide API Market Research Report 2025
The global market for Lenalidomide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 95
USD 2900.00 (Single User License)
Global Lenalidomide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lenalidomide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 77
USD 4250.00 (Single User License)
Global Lenalidomide API Market Insights, Forecast to 2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published: 2024-04-15
Pages: 95
USD 4900.00 (Single User License)
Lenalidomide API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published: 2024-02-23
Pages: 97
USD 3950.00 (Single User License)
Global Lenalidomide API Market Research Report 2024
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published: 2024-01-10
Pages: 85
USD 2900.00 (Single User License)